Since s.c. Pan02 tumour-bearing mice respond well to immune checkpoint blockade [28, 29], we developed a syngeneic orthotopic Pan02 model that better reflected the situation for patients and responded poorly to PD-L1 or CTLA-4 blockade. This evidence concerns the gene CTLA4 and neoplasm.